Review Article

Published in:
Volume 11 / Year 2022 / Issue 3

Development of Ph. Eur. standards for therapeutic monoclonal antibodies: infliximab case study

Page: 104-11

Abstract: This article describes the European Pharmacopoeia exploratory study on infliximab as a test case for developing public standards for monoclonal antibodies. The design and outcome of the feasibility study,… Read More »

Go Back Print